Two-Part Hematoxylin Composition With pH Shift to Prevent Precipitation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Hematoxylin staining solutions used in automated systems often form precipitates, leading to clogging and staining inconsistencies due to the formation of hematein-mordant complexes, which can impact diagnostic utility and require frequent module replacements.

Innovation Solution

A two-part hematoxylin stain composition is formulated at a low pH (less than 2.4) to stabilize the solution, preventing substantial precipitation, and a readjustment solution is used to raise the pH to a suitable staining level (2.45-2.6) just before use.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If hematoxylin staining solution is used in automated systems, then staining efficiency is improved, but precipitate formation occurs leading to clogging

Engineering Contradiction:
Improvestaining efficiencyVSAvoidsystem reliability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The hematoxylin staining system is divided into two separate components: a stabilized hematoxylin formulation (Component 1) and a readjustment solution (Component 2). Component 1 contains hematoxylin dye, mordant, and oxidant at low pH to prevent precipitate formation, while Component 2 provides base to raise pH to staining level. This segmentation prevents clogging by eliminating precipitate formation in the stored component, while maintaining staining efficiency when components are combined during use.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The pH parameter is changed to resolve the contradiction. The stabilized hematoxylin formulation is maintained at low pH (less than 2.4) to prevent precipitate formation and ensure system reliability. Just before use, the readjustment solution raises the pH to the staining level (2.45-2.6) to maintain staining efficiency. This dynamic pH adjustment allows the solution to be stable during storage yet effective during staining.

Inventive Principle:
Principle #35Parameter changes

2Loss of time

If hematoxylin solution is stored for extended periods, then availability is improved, but precipitate formation increases

Engineering Contradiction:
Improvestorage timeVSAvoidsolution stability
Core Design Contradiction:
Loss of timeVSStability of the object's composition

Solution Approach 1:

The hematoxylin formulation is pre-stabilized at low pH before storage to prevent precipitate formation during extended storage periods. The acidic environment (pH less than 2.4) is established in advance to maintain solution stability. When needed, the readjustment solution is added to raise pH to the staining level. This preliminary stabilization allows the solution to be stored indefinitely without precipitate formation.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The pH parameter is changed to resolve the contradiction between storage time and solution stability. By maintaining low pH (less than 2.4) in the stabilized hematoxylin formulation, the solution remains stable during extended storage. The readjustment solution provides base to raise pH to the staining level (2.45-2.6) just before use. This pH parameter change enables both long-term storage stability and effective staining performance.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If concentrated hematoxylin solution is used, then staining intensity is improved, but precipitate formation increases

Engineering Contradiction:
Improvestaining intensityVSAvoidprecipitate formation
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The concentrated hematoxylin staining function is separated from the precipitate formation problem through segmentation. Component 1 contains the concentrated hematoxylin dye, mordant, and oxidant at low pH to prevent precipitate formation. Component 2 provides base to raise pH to the staining level. This segmentation allows concentrated staining intensity to be achieved without precipitate formation, as the acidic environment prevents precipitation even at high concentrations.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The pH parameter is changed to resolve the contradiction between staining intensity and precipitate formation. The stabilized hematoxylin formulation is maintained at low pH (less than 2.4) to prevent precipitate formation even at concentrated levels. The readjustment solution raises the pH to the staining level (2.45-2.6) to enable intense staining. This pH parameter change allows concentrated staining without precipitate formation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The stabilized hematoxylin formulation remains precipitate-free for extended periods, ensuring consistent staining results and reducing maintenance issues in automated systems by preventing clogging and maintaining diagnostic accuracy.

Implementation Method 1

reducing the pH of a starting hematoxylin staining composition to a pH of less than 2.4, wherein the pH is reduced by adding an acid to the hematoxylin staining composition

Methodology Applied
Scientific EffectpH adjustment:

Implementation Method 2

The staining processes generally involve: (a) removing paraffin from a specimen affixed to a microscope slide and hydrating the specimen by soaking in water; (b) applying hematoxylin to stain cell nuclei; (c) removing excess hematoxylin by rinsing with water; (d) contacting the slide with a concentrated solution having a pH above 5.0 to turn the hematoxylin blue (e.g. a bluing solution)

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20260043720A1STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT
Publication Date: 2026.02.12 VENTANA MEDICAL SYSTEMS INC
  • US20260043720A1 patent drawing
  • US20260043720A1 patent drawing
  • US20260043720A1 patent drawing

AI summary

The present disclosure provides stabilized hematoxylin formulations having a pH of less than 2.4. The present disclosure also provides methods of using such stabilized hematoxylin formulations to stain biological samples.